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Background
We previously reported slow HIV-1 disease progression in
this population to be associated with the inherent host
HLA B allele-mediated ability to induce broader Gag T-cell
responses and faster disease progression to be more asso-
ciated with clade D than A. Since Gag escape mutations
often reduce viral fitness leading to significant reduction
in virus replication, in this study, we evaluated the immu-
nogenetic characteristics of clades A and D-associated
escape mutations that could be harnessed for vaccine
design.
Methods
The HIV-1 gag gene was sequenced to determine genetic
variability in 55 HIV-1 chronically infected, ART-naive
adults previously screened for Gag T-cell responses. The
proportion of individuals in which Gag-induced immune
escape occurred was determined in 46 individuals that
had sequence data. The proportion of B57/5801-driven
substitutions: A→P in p17 AISPRTLNAW and T242N in
p24 TSTLQEQIAW (TW10) both known to confer protec-
tion in early infection; and substitution A163G in p24
KAFSPEVIPMF (KF11) known to confer protection in
chronic infection was correlated with the infecting gag
clade.
Results
Clades A1, D, and inter-subtype recombinants A1/C, A1/
D occurred at frequencies 43%, 52%, 2.2% and 2.2%, (n
= 46), respectively. Substitution A→P occurred in 3/41 (1
vs.2), A1 and D respectively; T242N occurred in 5/41 (1
vs. 1 vs. 3), A1, A1/C and D, respectively. Immununoge-
netic substitution A163G in the Gag KF11 epitope, known
to confer protection in chronic HIV-1 infection, was
absent in the two recombinants, but occurred in 11/44
(11/20 clade A vs. 0/24 clade D); p = 0.00012, Fisher's
Exact.
Conclusion
These data suggest preferential, clade A-associated, immu-
nogenetic selection of a dominant Gag escape mutation
known to have an impact on virus replication in chronic
HIV-1 disease; this may partly account for the differential
disease progression we have observed in clade A and D
infection, this is also relevant to HIV vaccine develop-
ment.
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